2019 AAAAI/APFED Best Abstract on EGIDs Award Recipients Announced
February 25, 2019
Award winners recognized for best-scoring abstracts focused on eosinophilic gastrointestinal disease
(Atlanta, GA)— The American Partnership for Eosinophilic Disorders (APFED) today announced the two recipients of the 2019 AAAAI/APFED Best Abstract on EGIDs Awards. Presented at the Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), the awards recognize outstanding research abstracts on eosinophil-associated gastrointestinal diseases (EGIDs). APFED funded two $750 awards to the best-scoring abstracts by a Fellow-in-Training and a Member.
The awards are intended to help defray travel costs to the meeting so that the researchers may present their findings to their peers. Abstract award winners may go on to successfully compete for grants from APFED or from other funding mechanisms.
The 2019 AAAAI/APFED Best Abstracts on EGIDs recipients are Basil M. Kahwash, MD (Fellow-in-Training), The Ohio State University, Columbus, Ohio, for his abstract entitled “Peripheral Blood Microarray Analysis in Pediatric Patients with Eosinophilic Esophagitis,” and Catherine Sonaly Ferreira Martins, MD (Member), Division of Clinical Immunology and Allergy, Hospital das Clínicas, University of Sao Paulo, Sao Paulo, Brazil, for her abstract entitled “EoE, OIT and Anaphylaxis: an unsolved puzzle.”
The awards were made possible thanks to the generous donations to APFED’s HOPE on the Horizon Research Program, which has enabled the organization to contribute more than $2 million for the research of eosinophil-associated diseases since the fund began in 2005.
About the American Partnership for Eosinophilic Disorders (APFED)
The American Partnership for Eosinophilic Disorders (APFED) is a non-profit organization whose mission is to passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy. www.apfed.org
About the American Academy of Allergy, Asthma & Immunology (AAAAI)
The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has more than 7,000 members in the United States, Canada and 72 other countries. The AAAAI’s Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.